Carlyle Group Inc. - JASPER THERAPEUTICS INC ownership

JASPER THERAPEUTICS INC's ticker is and the CUSIP is 471871103. A total of 48 filers reported holding JASPER THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.50 and the average weighting 0.9%.

Quarter-by-quarter ownership
Carlyle Group Inc. ownership history of JASPER THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$6,054,467
-48.8%
8,761,8910.0%0.26%
-37.5%
Q2 2023$11,828,553
-25.0%
8,761,8910.0%0.42%
-10.4%
Q1 2023$15,771,4048,761,8910.47%
Other shareholders
JASPER THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Qiming U.S. Ventures Management, LLC 5,852,982$20,778,00019.52%
Velan Capital Investment Management LP 3,219,036$10,180,0009.45%
Abingworth LLP 5,628,558$19,531,0005.54%
SECTORAL ASSET MANAGEMENT INC 675,000$2,396,0000.42%
KINGDON CAPITAL MANAGEMENT, L.L.C. 540,000$1,917,0000.20%
Vahanian & Associates Financial Planning Inc. 10,000$36,0000.08%
Forefront Analytics, LLC 32,550$118,0000.04%
Citadel Advisors 2,994,580$10,631,0000.00%
FEDERATED HERMES, INC. 251,697$894,0000.00%
Ionic Capital Management LLC 100$00.00%
View complete list of JASPER THERAPEUTICS INC shareholders